Sanofi · 1 day ago
Head of Immunology Clinical Development
Morristown, NJ
Full-time
Hybrid
Director/Executive
10+ years expSanofi is an innovative global healthcare company dedicated to improving people's lives through science. The Head of Immunology Clinical Development will lead the clinical development organization, providing expertise and strategic leadership to ensure the success of clinical programs in immunology.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Lead the clinical development organization within the immunology TA (over 50 physicians and scientists), supporting, mentoring and coaching the clinical development teams across indications and assets. Ensure appropriate resourcing of the clinical teams based on the TA priorities
Provide subject matter expertise to all clinical development deliverables as a senior clinical development expert in the TA, including clinical development plans, protocols, primary data read-outs, clinical study reports and primary publications
Be a key thought partner for excellence in clinical development in collaboration with other immunology TA functional heads, including statistics, safety, regulatory, translational medicine and research
Strategic Leadership: Support the teams developing and implementing the clinical development strategy for the Immunology TA, aligning with organizational goals and managing specific development plans for products and indications. Ensure appropriate alignment across assets as well as appropriate prioritization based on TA goals
Serve as a member of the TA leadership team, participating the success of the TA management and portfolio development and optimization
Qualification
Required
Education: MD or MD/PhD, specialization in an area relevant to Immunology development is preferred (eg pulmonary, allergy/immunology, dermatology, gastroenterology)
Experience: 10+ years' experience in clinical development is preferred, with preference for development in immune-mediated diseases
Advantageous to have developed therapies across different immune-mediated indications and different sub-therapeutic areas. Preference for experience across different phases of development
Current or prior experience managing teams, with preference for prior experience managing larger teams
Significant regulatory experience, with preference for experience with global regulatory submissions
This position may require up to 25% overall travel
Preferred
Education: specialization in an area relevant to Immunology development is preferred (eg pulmonary, allergy/immunology, dermatology, gastroenterology)
Experience: 10+ years' experience in clinical development is preferred, with preference for development in immune-mediated diseases
Advantageous to have developed therapies across different immune-mediated indications and different sub-therapeutic areas. Preference for experience across different phases of development
Current or prior experience managing teams, with preference for prior experience managing larger teams
Significant regulatory experience, with preference for experience with global regulatory submissions
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
10001+ employees
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Leadership Team
Paul Hudson
Chief Executive Officer
Francois-Xavier Roger
Chief Financial Officer
Recent News
2026-01-06
BioWorld Financial Watch
2026-01-06
2026-01-06
Company data provided by crunchbase